Ignite Creation Date:
2025-12-24 @ 7:34 PM
Ignite Modification Date:
2025-12-25 @ 5:15 PM
Study NCT ID:
NCT04718103
Status:
COMPLETED
Last Update Posted:
2024-11-29
First Post:
2021-01-18
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-04
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-11
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-18
First Submit QC Date:
None
Study First Post Date:
2021-01-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-10-08
Results First Submit QC Date:
None
Results First Post Date:
2024-11-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-22
Last Update Post Date:
2024-11-29
Last Update Post Date Type:
ACTUAL